A structured path to identify what works and why.
We apply a methodical approach—much like traditional drug discovery—tailored to digital modalities. This includes uncovering Mechanisms of Action (MOA) for Digital Therapeutics (DTx) and defining Contexts of Use (COU) or Contexts of Interest (COI) for Digital Biomarkers and Clinical Measures.
